Status:
COMPLETED
Angiography-Derived Quantitative Functional Assessment Versus Pressure-Derived FFR and IMR: The FAIR Study
Lead Sponsor:
Shenzhen Raysight Intelligent Medical Technology Co., Ltd.
Collaborating Sponsors:
Renmin Hospital of Wuhan University
Yan'an Affiliated Hospital of Kunming Medical University
Conditions:
Coronary Artery Disease
Heart Diseases
Eligibility:
All Genders
18+ years
Brief Summary
Coronary angiography-derived FFR assessment (AngioQFA) is a novel technique for physiological lesion assessment based on 3-dimensional (3D) quantitative coronary angiography (QCA) and virtual hyperemi...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- General
- Age ≥18 years.
- Coronary angiography is required for patients with suspected or confirmed coronary artery disease.
- The subject has been informed of the nature of the study, agrees to its provisions and has provided written informed consent.
- Angiographic
- Diameter stenosis of 30%-90% by visual estimate
- Reference vessel size ≥2 mm in stenotic segment by visual estimate
Exclusion
- Patients meeting any of the following criteria will be excluded:
- General
Key Trial Info
Start Date :
September 13 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 14 2024
Estimated Enrollment :
330 Patients enrolled
Trial Details
Trial ID
NCT06039748
Start Date
September 13 2023
End Date
January 14 2024
Last Update
May 16 2025
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Jieyang People's Hospital
Jieyang, Guangdong, China
2
The Eighth Affiliated Hospital of Sun Yat-Sen University
Shenzhen, Guangdong, China, 518033
3
Renmin Hospital of Wuhan University
Wuhan, Hubei, China, 430090
4
Yan'an Affiliated Hospital of Kunming Medical University
Kunming, Yunnan, China, 650051